These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 6553424)
41. Effects of thorium dioxide upon blood clotting and platelets. I. In vitro studies. Hjort PF; McGehee WG; Rapaport SI Thromb Diath Haemorrh; 1966 Dec; 16(3):333-53. PubMed ID: 5996663 [No Abstract] [Full Text] [Related]
42. The possible role of platelets in bypassing the contact phase of blood coagulation. Walsh PN; Tuszynski GP; Greengard JS; Griffin JH Haematologia (Budap); 1984; 17(2):169-78. PubMed ID: 6534825 [TBL] [Abstract][Full Text] [Related]
43. [Protein synthesis induced by vitamin K deficiency]. Hemker HC Nouv Rev Fr Hematol; 1970; 10(5):645-51. PubMed ID: 4250287 [No Abstract] [Full Text] [Related]
44. Role of high molecular weight kininogen in contact activation. van Iwaarden F; Bouma BN Semin Thromb Hemost; 1987 Jan; 13(1):15-24. PubMed ID: 2436301 [No Abstract] [Full Text] [Related]
45. The chemistry of blood coagulation. Baugh RF; Hougie C Clin Haematol; 1979 Feb; 8(1):3-30. PubMed ID: 367664 [No Abstract] [Full Text] [Related]
46. Inactivation of Hageman factor by diisopropylfluorophosphate (DFP). BECKER EL J Lab Clin Med; 1960 Jul; 56():136-8. PubMed ID: 13798074 [No Abstract] [Full Text] [Related]
47. Contact activation of Hageman factor and the interaction of Hageman factor and plasma thromboplastin antecedent. Haanen C; Morselt G; Schoenmakers J Thromb Diath Haemorrh; 1967 May; 17(3-4):307-20. PubMed ID: 5626768 [No Abstract] [Full Text] [Related]
48. [Proteases which relate to kallikrein-kinin system and blood coagulation system (author's transl)]. Suzuki T Tanpakushitsu Kakusan Koso; 1980; 25(6):547-60. PubMed ID: 7010426 [No Abstract] [Full Text] [Related]
49. Initiation of intrinsic blood coagulation. Kurachi K; Ohkubo I; Heimark RL; Fujikawa K; Davie EW Adv Exp Med Biol; 1983; 156():39-44. PubMed ID: 6190373 [No Abstract] [Full Text] [Related]
50. An inhibitor from corn blocks the hypotensive action of plasma protein fraction and active Hageman factor. Marks E; Hojima Y; Frech ME; Keiser H; Pisano JJ Thromb Res; 1981 Jul 1-15; 23(1-2):97-102. PubMed ID: 6914060 [No Abstract] [Full Text] [Related]
51. Far from the heart: Counteracting coagulation. Esmon CT Nat Med; 2010 Jul; 16(7):759-60. PubMed ID: 20613754 [No Abstract] [Full Text] [Related]
52. [Filtrated plasma, a reagent for testing the activity of coagulation factor VII]. POPPA C; POPA I Med Interna (Bucur); 1961 Oct; 13():1439-44. PubMed ID: 14487979 [No Abstract] [Full Text] [Related]
53. [A method for determination of the factor VII inhibiting effect in plasma and in serum]. JURGENS J Klin Wochenschr; 1955 Feb; 33(5-6):143-4. PubMed ID: 14354886 [No Abstract] [Full Text] [Related]
54. Intermediate reactions in blood coagulation. MANN FD; HURN MM Am J Physiol; 1953 Oct; 175(1):65-8. PubMed ID: 13114352 [No Abstract] [Full Text] [Related]
55. Major inhibitors of the contact phase coagulation factors. Schapira M Semin Thromb Hemost; 1987 Jan; 13(1):69-78. PubMed ID: 2436302 [No Abstract] [Full Text] [Related]
56. Alpha 1-antitrypsin-Pittsburgh: a potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf. Scott CF; Carrell RW; Glaser CB; Lewis JH; Colman RW Trans Assoc Am Physicians; 1985; 98():344-51. PubMed ID: 3879844 [TBL] [Abstract][Full Text] [Related]
57. Chemistry of the hemostatic mechanism and its relationship to the action of heparin. Rosenberg RD Fed Proc; 1977 Jan; 36(1):10-8. PubMed ID: 63388 [No Abstract] [Full Text] [Related]